157 related articles for article (PubMed ID: 23416022)
1. Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy.
Banki E; Degrell P; Kiss P; Kovacs K; Kemeny A; Csanaky K; Duh A; Nagy D; Toth G; Tamas A; Reglodi D
Peptides; 2013 Apr; 42():125-30. PubMed ID: 23416022
[TBL] [Abstract][Full Text] [Related]
2. The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney.
Horvath G; Opper B; Reglodi D
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591326
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of PACAP on Ischemia/Reperfusion-Induced Kidney Injury of Male and Female Rats: Gender Differences.
Laszlo E; Juhasz T; Varga A; Czibere B; Kovacs K; Degrell P; Horvath G; Jancso G; Szakaly P; Tamas A; Reglodi D
J Mol Neurosci; 2019 Jul; 68(3):408-419. PubMed ID: 30443839
[TBL] [Abstract][Full Text] [Related]
4. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
[TBL] [Abstract][Full Text] [Related]
5. PACAP promotes neuron survival in early experimental diabetic retinopathy.
Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.
Banki E; Kovacs K; Nagy D; Juhasz T; Degrell P; Csanaky K; Kiss P; Jancso G; Toth G; Tamas A; Reglodi D
J Mol Neurosci; 2014 Nov; 54(3):300-9. PubMed ID: 24535559
[TBL] [Abstract][Full Text] [Related]
7. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of oxymatrine on experimental diabetic nephropathy.
Guo C; Han F; Zhang C; Xiao W; Yang Z
Planta Med; 2014 Mar; 80(4):269-76. PubMed ID: 24535719
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
10. Zinc supplementation alleviates the progression of diabetic nephropathy by inhibiting the overexpression of oxidative-stress-mediated molecular markers in streptozotocin-induced experimental rats.
Barman S; Pradeep SR; Srinivasan K
J Nutr Biochem; 2018 Apr; 54():113-129. PubMed ID: 29331868
[TBL] [Abstract][Full Text] [Related]
11. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion.
Horvath G; Racz B; Reglodi D; Kovacs K; Kiss P; Gallyas F; Bognar Z; Szabo A; Magyarlaki T; Laszlo E; Lubics A; Tamas A; Toth G; Szakaly P
J Mol Neurosci; 2010 Nov; 42(3):411-8. PubMed ID: 20229361
[TBL] [Abstract][Full Text] [Related]
12. Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response.
Khanra R; Dewanjee S; K Dua T; Sahu R; Gangopadhyay M; De Feo V; Zia-Ul-Haq M
J Transl Med; 2015 Jan; 13():6. PubMed ID: 25591455
[TBL] [Abstract][Full Text] [Related]
13. The augmentation of pituitary adenylate cyclase-activating polypeptide (PACAP) in streptozotocin-induced diabetic rats.
Tamakawa H; Miyata A; Satoh K; Miyake Y; Matsuo H; Arimura A; Kangawa K
Peptides; 1998; 19(9):1497-502. PubMed ID: 9864055
[TBL] [Abstract][Full Text] [Related]
14. [Examination of cytoprotective and anti-inflammatory effect of PACAP-38 on small bowel autotransplantation].
Nedvig K; Szabó G; Csukás D; Sándor J; Németh J; Kovács K; Reglődi D; Kemény A; Wéber G; Ferencz A
Magy Seb; 2013 Oct; 66(5):250-5. PubMed ID: 24144817
[TBL] [Abstract][Full Text] [Related]
15. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuries.
Sakamoto K; Kuno K; Takemoto M; He P; Ishikawa T; Onishi S; Ishibashi R; Okabe E; Shoji M; Hattori A; Yamaga M; Kobayashi K; Kawamura H; Tokuyama H; Maezawa Y; Yokote K
J Diabetes Res; 2015; 2015():727152. PubMed ID: 25821833
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
Kadian S; Mahadevan N; Balakumar P
Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
[TBL] [Abstract][Full Text] [Related]
18. Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion.
Szabo A; Danyadi B; Bognar E; Szabadfi K; Fabian E; Kiss P; Mester L; Manavalan S; Atlasz T; Gabriel R; Toth G; Tamas A; Reglodi D; Kovacs K
Neurosci Lett; 2012 Aug; 523(2):93-8. PubMed ID: 22750211
[TBL] [Abstract][Full Text] [Related]
19. Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats.
Abdelrahman AM; Al Salam S; Al Suleimani Y; Ashique M; Manoj P; Ali BH
Eur J Pharmacol; 2020 Apr; 873():172960. PubMed ID: 32001219
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
Maugeri G; D'Amico AG; Bucolo C; D'Agata V
Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
